Company registration number 08344447 (England and Wales)
NORTHERN HEALTHCARE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
NORTHERN HEALTHCARE LIMITED
COMPANY INFORMATION
Directors
Mr D Flaherty
Mrs N M Forshaw
(Appointed 1 April 2024)
Company number
08344447
Registered office
Barton Hall
Hardy Street
Eccles
Manchester
Lancashire
United Kingdom
M30 7NB
Auditor
Hammond McNulty LLP
Bank House
Market Square
Congleton
Cheshire
United Kingdom
CW12 1ET
NORTHERN HEALTHCARE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Profit and loss account
8
Statement of comprehensive income
9
Balance sheet
10
Statement of changes in equity
11
Notes to the financial statements
12 - 25
NORTHERN HEALTHCARE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -

The directors present the strategic report for the year ended 31 March 2025.

Review of the business

The key financial and other performance indicators during the year were as follows:

Turnover increased by 11% compared to the prior year, being largely a result of an increase in the number of people that the company supports (during the year the company opened three new services, Moss Lodge in Rochdale (18 beds), Saxon House in Bury (13 beds) and Liberty House in Radcliffe (6 beds)) as well as inflationary related increases in the weekly fee for the support provided. However, Operating profit over the same period decreased by 8%, reflecting the comparatively high payroll and void costs in the post-opening period of the three new services, inflationary cost pressures and also a number of one-time costs (see note 4). Notwithstanding the reduction in Operating profit, EBITDA, which is one of the key financial indicators that management uses to monitor performance of the business, is comparable year on year at approximately £2.5m. Year on year, equity shareholder funds increased by 39%, being largely a function of the profit after tax less the payment of a dividend to shareholders.

On 31 March 2025 the company refinanced its bank debt. The new facility totals £5.1m and has a maturity date in 2030.

Principal risks and uncertainties

The company’s management structures, coupled with its policies and procedures are designed to support the achievements of business objectives while controlling the risks associated with the environment in which it operates.

The principal risks and uncertainties affecting the company are as follows:

Public finances and spending cuts

Publicly funded entities could allocate less money to the services that the company operates. However, the company’s operational teams continue to focus on their strong relationships with commissioners of the company’s services.

National Living Wage increases

The healthcare sector employs a significant proportion of people who have salaries based on, or close to, the National Living Wage / Real Living Wage. As such, increases in this statutory rate, which are in excess of inflationary increases in income, could have an impact on the company’s profitability and cash flow. However, the company carefully budgets for increases in statutory rates and the impact on profitability and cash flow. In addition, the company's external profile and fee income may benefit from higher pay rates.

Interest rate risk

The cost of the company’s variable rate borrowings is directly impacted by changes in SONIA, thereby impacting the cash cost of those borrowings. Again, the company closely monitors potential changes in the cost of its borrowings and plans for these in cash flow forecasts.

Development and performance

Following another successful year the company is planning to continue to develop the number of locations in which it provides support, with a number of potential new sites being discussed with commissioners at any point in time. The growth strategy is driven by specialist sector knowledge and a proven understanding of supported living, supported by a strong commitment to delivering outstanding care. We are recognised for our expertise in delivering high-quality mental health support services that promote recovery, independence, and well-being.

We would like to take this opportunity to thank all of our team members across the whole business for all their hard work and commitment throughout the year.

NORTHERN HEALTHCARE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -

On behalf of the board

Mr D Flaherty
Director
23 December 2025
NORTHERN HEALTHCARE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -

The directors present their annual report and financial statements for the year ended 31 March 2025.

Principal activities

The principal activity of the company continued to be the provision of supported living services for individuals who require clinical support due to a mental health diagnosis, learning disability or autism.

Results and dividends

The results for the year are set out on page 8.

Ordinary dividends were paid amounting to £282,233. The directors do not recommend payment of a final dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr A P Mancey-Johnson
(Resigned 12 December 2024)
Mr D Flaherty
Ms A D Gribbin
(Resigned 12 December 2024)
Mrs D A Cropper
(Resigned 30 April 2025)
Mrs N M Forshaw
(Appointed 1 April 2024)
Mr A J Hannah-Briggs
(Appointed 1 April 2024 and resigned 30 April 2025)
Disabled persons

Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

Employee involvement

The company's policy is to consult and discuss with employees, through staff meetings, matters likely to affect employees' interests.

 

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

In preparing these financial statements, the directors are required to:

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

NORTHERN HEALTHCARE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
Mr D Flaherty
Director
23 December 2025
NORTHERN HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF NORTHERN HEALTHCARE LIMITED
- 5 -
Opinion

We have audited the financial statements of Northern Healthcare Limited (the 'company') for the year ended 31 March 2025 which comprise the profit and loss account, the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

NORTHERN HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF NORTHERN HEALTHCARE LIMITED (CONTINUED)
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

We obtained an understanding of laws and regulations that affect the company, focusing on those that had a direct effect on the financial statements or that had a fundamental effect on its operations. Key laws and regulations that we identified included the UK Companies Act, tax legislation, and employment legislation.

 

We enquired of the directors, reviewed correspondence with HMRC and reviewed legal fees for evidence of non-compliance with relevant laws and regulations. We also reviewed controls the directors have in place to ensure compliance.

 

We gained an understanding of the controls that the directors have in place to prevent and detect fraud. We enquired of the directors about any incidences of fraud that had taken place during the accounting period.

 

The risk of fraud and non-compliance with laws and regulations was discussed within the audit team and tests were planned and performed to address these risks. We identified the potential for fraud in the following areas:

related party transactions, revenue recognition, cut off, laws and regulations and management override.

 

We reviewed the financial statements' disclosures and tested to supporting documentation to assess compliance with the relevant laws and regulations discussed above.

 

We enquired of the directors about actual and potential litigation and claims.

 

We performed analytical procedures at the planning stage to identify any unusual or unexpected relationships that might indicate risks of material misstatement due to fraud.

 

In addressing the risk of fraud due to management override of internal controls we tested the appropriateness of journal entries and assessed whether the judgements made in making accounting estimates were indicative of a potential bias.

 

NORTHERN HEALTHCARE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF NORTHERN HEALTHCARE LIMITED (CONTINUED)
- 7 -

Due to the inherent limitations of an audit, there is an unavoidable risk that we may not have detected some material misstatements in the financial statements, even though we have properly planned and performed our audit in accordance with auditing standards. For example, as with any audit, there remained a higher risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal controls. We are not responsible for preventing fraud or non-compliance with laws and regulations and cannot be expected to detect all fraud and non-compliance with laws and regulations.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Marie Ann Shenton FCCA (Senior Statutory Auditor)
For and on behalf of Hammond McNulty LLP, Statutory Auditor
Chartered Certified Accountants
Bank House
Market Square
Congleton
Cheshire
CW12 1ET
United Kingdom
23 December 2025
NORTHERN HEALTHCARE LIMITED
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2025
2024
Notes
£
£
Turnover
3
14,428,290
12,974,053
Cost of sales
(1,287,783)
(1,066,737)
Gross profit
13,140,507
11,907,316
Administrative expenses
(11,748,543)
(10,427,717)
Other operating income
823
28,429
Operating profit
7
1,392,787
1,508,028
Interest receivable and similar income
8
240
-
0
Interest payable and similar expenses
9
(348,834)
(538,228)
Profit before taxation
1,044,193
969,800
Tax on profit
10
(255,997)
(281,273)
Profit for the financial year
788,196
688,527

The profit and loss account has been prepared on the basis that all operations are continuing operations.

NORTHERN HEALTHCARE LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025
- 9 -
2025
2024
£
£
Profit for the year
788,196
688,527
Other comprehensive income
Revaluation of tangible fixed assets
-
0
80,000
Total comprehensive income for the year
788,196
768,527
NORTHERN HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 10 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
12
188,434
368,876
Tangible assets
13
396,820
434,578
585,254
803,454
Current assets
Debtors
14
6,355,464
4,571,020
Cash at bank and in hand
950,503
741,654
7,305,967
5,312,674
Creditors: amounts falling due within one year
15
(1,239,957)
(1,783,310)
Net current assets
6,066,010
3,529,364
Total assets less current liabilities
6,651,264
4,332,818
Creditors: amounts falling due after more than one year
16
(4,760,000)
(2,933,333)
Provisions for liabilities
Deferred tax liability
18
98,094
112,279
(98,094)
(112,279)
Net assets
1,793,170
1,287,206
Capital and reserves
Called up share capital
21
105
104
Revaluation reserve
22
80,000
80,000
Profit and loss reserves
1,713,065
1,207,102
Total equity
1,793,170
1,287,206

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
Mr D Flaherty
Director
Company registration number 08344447 (England and Wales)
NORTHERN HEALTHCARE LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 11 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 April 2023
104
-
0
692,875
692,979
Year ended 31 March 2024:
Profit
-
-
688,527
688,527
Other comprehensive income:
Revaluation of tangible fixed assets
-
80,000
-
80,000
Total comprehensive income
-
80,000
688,527
768,527
Dividends
11
-
-
(174,300)
(174,300)
Balance at 31 March 2024
104
80,000
1,207,102
1,287,206
Year ended 31 March 2025:
Profit and total comprehensive income
-
-
788,196
788,196
Issue of share capital
21
1
-
-
1
Dividends
11
-
-
(282,233)
(282,233)
Balance at 31 March 2025
105
80,000
1,713,065
1,793,170
NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 12 -
1
Accounting policies
Company information

Northern Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is Barton Hall, Hardy Street, Eccles, Manchester, Lancashire, United Kingdom, M30 7NB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

 

Freehold property have been measured at fair value.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

 

 

The financial statements of the company are consolidated in the financial statements of Citipool Holdings Limited. These consolidated financial statements are available from its registered office, Bank House, Market Square, Congleton, Cheshire, United Kingdom, CW12 1ET.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured at the fair value of the consideration received or receivable, net of value added tax and other sales-related taxes.

 

The principal source of revenue is the provision of supported living services to individuals with mental health needs, learning disabilities, or autism. Revenue from supported living services is recognised over time as the services are delivered.

 

Where invoices are raised in advance of the delivery of services, the amounts are recognised as deferred income within creditors until the services are provided. Where services have been delivered but not yet invoiced, the revenue is recognised as accrued income within debtors.

 

Any discounts, rebates, or adjustments to funding are recognised as a reduction to revenue in the period to which they relate.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 13 -
1.4
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets over their useful lives on the following bases:

Software
2 years straight line
Patents, licences & contracts
4 years straight line
1.5
Tangible fixed assets

With the exception of freehold property, property, plant and equipment are stated at cost less accumulated depreciation and any recognised impairment losses. Freehold property is stated in the balance sheet at revalued amounts, being the fair value on the date of revaluation less any subsequent depreciation and impairment losses. Revaluations are performed with sufficient regularity such that the carrying amount does not differ materially from that which could be determined using fair values at the reporting end date.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% straight line
Leasehold improvements
20 years straight line
Plant and equipment
20% reducing balance
Fixtures and fittings
20% reducing balance
Computers
3 years straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 14 -

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 15 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Other financial liabilities

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

 

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.10
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 16 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.11
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.12
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.13
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

1.14
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 17 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The judgements and estimates reviewed are as follows:

 

- Revenue recognition in supported living: judgment that revenue is recognised over time as services are delivered; estimates of accrued income and deferred income where billing does not align with delivery.
- Recoverability of related party receivables: significant carrying amount £3,076,747; assessment considers counterparty creditworthiness, post‑year‑end cash receipts, and support from the parent.
- Useful lives and components for buildings: estimation of appropriate useful lives and componentisation for depreciation.
- Impairment indicators for software/contracts: review of usage and future benefits supporting carrying amount £188,434.

 

3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Mental Health Supported Living services
14,428,290
12,974,053
2025
2024
£
£
Other revenue
Interest income
240
-
Grants received
-
738
Other recharged income
823
27,691

All turnover is derived in the United Kingdom.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 18 -
4
Exceptional items
Within the Profit before taxation there are the following items of expenditure/(income) which are one off or exceptional in nature:
2025
2024
£
£
Expenditure / (income)
Included within Administrative expenses:
New site setup costs
107,060
96,795
Consultancy fees
202,714
-
Site closure costs
63,153
-
Redundancy and other remuneration
159,974
-
Debt refinancing costs
40,700
-
Registered provider support costs (net)
-
120,680
Settlement claim
-
7,000
Amounts due from related parties
-
183,086
Professional fees
81,650
108,370
Board recruitment costs
-
103,130
Other
79,893
18,680
Included within Interest payable and similar expenses
Loan impairment *
-
150,000
735,144
787,741
* This is the impairment of an amount due from a connected company.
5
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
355
356

Their aggregate remuneration comprised:

2025
2024
£
£
Wages and salaries
8,517,770
7,442,115
Social security costs
789,192
636,507
Pension costs
167,919
130,901
9,474,881
8,209,523
NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 19 -
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
576,759
453,259
Company pension contributions to defined contribution schemes
28,037
14,089
604,796
467,348

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 4 (2024 - 4).

Remuneration disclosed above includes the following amounts paid to the highest paid director:
2025
2024
£
£
Remuneration for qualifying services
190,000
163,165
Company pension contributions to defined contribution schemes
14,535
3,522
7
Operating profit
2025
2024
Operating profit for the year is stated after charging/(crediting):
£
£
Government grants
(823)
(28,429)
Fees payable to the company's auditor for the audit of the company's financial statements
24,000
15,000
Depreciation of owned tangible fixed assets
107,560
115,917
Amortisation of intangible assets
198,442
247,590
Operating lease charges
89,293
89,860
8
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
178
-
0
Other interest income
62
-
0
Total income
240
-
0
NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 20 -
9
Interest payable and similar expenses
2025
2024
£
£
Interest on bank overdrafts and loans
348,834
387,312
Other interest on financial liabilities
-
0
150,000
Other interest
-
0
916
348,834
538,228
10
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
270,182
251,413
Adjustments in respect of prior periods
-
0
41,650
Total current tax
270,182
293,063
Deferred tax
Origination and reversal of timing differences
(14,185)
(11,790)
Total tax charge
255,997
281,273

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
Profit before taxation
1,044,193
969,800
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
261,048
242,450
Tax effect of expenses that are not deductible in determining taxable profit
3,885
4,573
Group relief
(8,936)
(7,400)
Under/(over) provided in prior years
-
0
41,650
Taxation charge for the year
255,997
281,273
11
Dividends
2025
2024
£
£
Interim paid
282,233
174,300
NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 21 -
12
Intangible fixed assets
Software
Patents, licences & contracts
Total
£
£
£
Cost
At 1 April 2024
846,600
40,000
886,600
Additions
18,000
-
0
18,000
At 31 March 2025
864,600
40,000
904,600
Amortisation and impairment
At 1 April 2024
477,724
40,000
517,724
Amortisation charged for the year
198,442
-
0
198,442
At 31 March 2025
676,166
40,000
716,166
Carrying amount
At 31 March 2025
188,434
-
0
188,434
At 31 March 2024
368,876
-
0
368,876
13
Tangible fixed assets
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
£
£
Cost or valuation
At 1 April 2024
80,000
81,914
26,968
545,699
276,311
1,010,892
Additions
-
0
18,982
-
0
23,448
27,372
69,802
At 31 March 2025
80,000
100,896
26,968
569,147
303,683
1,080,694
Depreciation and impairment
At 1 April 2024
-
0
10,543
12,578
334,192
219,001
576,314
Depreciation charged in the year
1,600
5,045
2,878
46,991
51,046
107,560
At 31 March 2025
1,600
15,588
15,456
381,183
270,047
683,874
Carrying amount
At 31 March 2025
78,400
85,308
11,512
187,964
33,636
396,820
At 31 March 2024
80,000
71,371
14,390
211,507
57,310
434,578

Land and buildings with a carrying amount of £80,000 were revalued at 11th January 2024 by Christopher Wilson MRICS of Chris Wilson Associates, independent valuers not connected with the company, on the basis of market value. The valuation conforms to International Valuation Standards and was based on recent market transactions on arm's length terms for similar properties.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
13
Tangible fixed assets
(Continued)
- 22 -

The revaluation surplus is disclosed in note 22.

14
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
889,070
1,282,755
Other debtors
5,239,474
3,016,078
Prepayments and accrued income
226,920
272,187
6,355,464
4,571,020

Other debtors includes £2,121,761 (2024: £NIL) due in relation to the refinancing of the company's bank debt. The money was received on 1 April 2025.

15
Creditors: amounts falling due within one year
2025
2024
Notes
£
£
Bank loans
17
340,000
400,000
Trade creditors
184,882
416,765
Corporation tax
71,714
251,413
Other taxation and social security
162,300
161,154
Deferred income
19
365,291
247,548
Other creditors
24,022
80,287
Accruals and deferred income
91,748
226,143
1,239,957
1,783,310
16
Creditors: amounts falling due after more than one year
2025
2024
Notes
£
£
Bank loans and overdrafts
17
4,760,000
2,933,333
17
Loans and overdrafts
2025
2024
£
£
Bank loans
5,100,000
3,333,333
Payable within one year
340,000
400,000
Payable after one year
4,760,000
2,933,333

The long-term loans are secured by a fixed and floating charge over the assets of the business.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
17
Loans and overdrafts
(Continued)
- 23 -

On 31 March 2025 the company refinanced its bank loan. The new facility pays interest of SONIA plus 6% and has a repayment term of 60 months with the final repayment due in March 2030.

18
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
98,094
112,279
2025
Movements in the year:
£
Liability at 1 April 2024
112,279
Credit to profit or loss
(14,185)
Liability at 31 March 2025
98,094
19
Deferred income
2025
2024
£
£
Other deferred income
365,291
247,548
20
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
167,919
130,901

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 24 -
21
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100
100
100
100
Ordinary A shares of £1 each
1
1
1
1
Ordinary B shares of £1 each
1
1
1
1
Ordinary C shares of £1 each
1
1
1
1
Ordinary D shares of £1 each
1
1
1
1
Ordinary E shares of £1 each
1
-
1
-
105
104
105
104

At the year end the company had 6 classes of shares. The alphabet shares only have rights to dividends attached to them. The ordinary shares have full rights attached to them, including the entitlement to dividends and to vote. The alphabet shares were bought back by the company on 30 April 2025.

22
Revaluation reserve

The revaluation reserve relates to the fair value of the freehold property disclosed in note 12.

23
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2025
2024
£
£
Within one year
27,608
23,006
24
Related party transactions
Transactions with related parties

During the year the company entered into the following transactions with related parties:

 

i)    Sales invoices raised to related parties for the recharge of costs incurred by the company and other recharges:

Sales
Sales
Purchases
Purchases
2025
2024
2025
2024
£
£
£
£
Other related parties
823
26,029
551,537
135,070
NORTHERN HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
24
Related party transactions
(Continued)
- 25 -
Administrative costs
2025
2024
£
£
Other related parties
28,386
194,366

The following amounts were outstanding at the reporting end date:

2025
2024
Amounts due from related parties
£
£
Entities with control, joint control or significant influence over the company
3,042,763
3,009,716
Other related party balances
33,984
35,219
25
Ultimate controlling party

The ultimate parent company of Northern Healthcare Limited is Citipool Holdings Limited, incorporated in England and Wales.

 

There is no ultimate controlling party.

 

The largest and smallest group in which the results of the company are consolidated is that headed by Citipool Holdings Limited, incorporated in England and Wales. The consolidated accounts of this company are available to the public and may be obtained from Companies House, Crown Way, Cardiff, CF14 3UZ. No other group accounts include the results of the company.

2025-03-312024-04-01falsefalsefalseCCH SoftwareCCH Accounts Production 2025.300Mr A P Mancey-JohnsonMr D FlahertyMs A D GribbinMrs D A CropperMrs N M ForshawMr A J Hannah-Briggs083444472024-04-012025-03-3108344447bus:Director22024-04-012025-03-3108344447bus:Director52024-04-012025-03-3108344447bus:Director12024-04-012025-03-3108344447bus:Director32024-04-012025-03-3108344447bus:Director42024-04-012025-03-3108344447bus:Director62024-04-012025-03-3108344447bus:RegisteredOffice2024-04-012025-03-31083444472025-03-31083444472023-04-012024-03-3108344447core:RetainedEarningsAccumulatedLosses2023-04-012024-03-3108344447core:RetainedEarningsAccumulatedLosses2024-04-012025-03-3108344447core:RevaluationReserve2024-04-012025-03-3108344447core:OtherResidualIntangibleAssets2025-03-3108344447core:OtherResidualIntangibleAssets2024-03-3108344447core:ComputerSoftware2025-03-3108344447core:PatentsTrademarksLicencesConcessionsSimilar2025-03-3108344447core:ComputerSoftware2024-03-3108344447core:PatentsTrademarksLicencesConcessionsSimilar2024-03-31083444472024-03-3108344447core:LandBuildingscore:OwnedOrFreeholdAssets2025-03-3108344447core:LeaseholdImprovements2025-03-3108344447core:PlantMachinery2025-03-3108344447core:FurnitureFittings2025-03-3108344447core:ComputerEquipment2025-03-3108344447core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3108344447core:LeaseholdImprovements2024-03-3108344447core:PlantMachinery2024-03-3108344447core:FurnitureFittings2024-03-3108344447core:ComputerEquipment2024-03-3108344447core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3108344447core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3108344447core:Non-currentFinancialInstrumentscore:AfterOneYear2025-03-3108344447core:Non-currentFinancialInstrumentscore:AfterOneYear2024-03-3108344447core:CurrentFinancialInstruments2025-03-3108344447core:CurrentFinancialInstruments2024-03-3108344447core:ShareCapital2025-03-3108344447core:ShareCapital2024-03-3108344447core:RevaluationReserve2025-03-3108344447core:RevaluationReserve2024-03-3108344447core:RetainedEarningsAccumulatedLosses2025-03-3108344447core:RetainedEarningsAccumulatedLosses2024-03-3108344447core:ShareCapital2023-03-3108344447core:RevaluationReserve2023-03-3108344447core:RetainedEarningsAccumulatedLosses2023-03-3108344447core:ShareCapitalOrdinaryShareClass12025-03-3108344447core:ShareCapitalOrdinaryShareClass12024-03-3108344447core:ShareCapitalOrdinaryShareClass22025-03-3108344447core:ShareCapitalOrdinaryShareClass22024-03-3108344447core:ShareCapitalOrdinaryShareClass32025-03-3108344447core:ShareCapitalOrdinaryShareClass32024-03-3108344447core:ShareCapitalOrdinaryShareClass42025-03-3108344447core:ShareCapitalOrdinaryShareClass42024-03-3108344447core:ShareCapitalOrdinaryShareClass52025-03-3108344447core:ShareCapitalOrdinaryShareClass52024-03-3108344447core:ShareCapitalOrdinaryShares2025-03-3108344447core:ShareCapitalOrdinaryShares2024-03-3108344447core:ShareCapital2024-04-012025-03-3108344447core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108344447core:ComputerSoftware2024-04-012025-03-3108344447core:PatentsTrademarksLicencesConcessionsSimilar2024-04-012025-03-3108344447core:LandBuildingscore:OwnedOrFreeholdAssets2024-04-012025-03-3108344447core:LeaseholdImprovements2024-04-012025-03-3108344447core:PlantMachinery2024-04-012025-03-3108344447core:FurnitureFittings2024-04-012025-03-3108344447core:ComputerEquipment2024-04-012025-03-310834444712024-04-012025-03-310834444712023-04-012024-03-3108344447core:UKTax2024-04-012025-03-3108344447core:UKTax2023-04-012024-03-3108344447core:ComputerSoftware2024-03-3108344447core:PatentsTrademarksLicencesConcessionsSimilar2024-03-31083444472024-03-3108344447core:ComputerSoftwarecore:ExternallyAcquiredIntangibleAssets2024-04-012025-03-3108344447core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2024-04-012025-03-3108344447core:ExternallyAcquiredIntangibleAssets2024-04-012025-03-3108344447core:LandBuildingscore:OwnedOrFreeholdAssets2024-03-3108344447core:LeaseholdImprovements2024-03-3108344447core:PlantMachinery2024-03-3108344447core:FurnitureFittings2024-03-3108344447core:ComputerEquipment2024-03-3108344447core:Non-currentFinancialInstruments2025-03-3108344447core:Non-currentFinancialInstruments2024-03-3108344447bus:OrdinaryShareClass12024-04-012025-03-3108344447bus:OrdinaryShareClass22024-04-012025-03-3108344447bus:OrdinaryShareClass32024-04-012025-03-3108344447bus:OrdinaryShareClass42024-04-012025-03-3108344447bus:OrdinaryShareClass52024-04-012025-03-3108344447bus:OrdinaryShareClass12025-03-3108344447bus:OrdinaryShareClass12024-03-3108344447bus:OrdinaryShareClass22025-03-3108344447bus:OrdinaryShareClass22024-03-3108344447bus:OrdinaryShareClass32025-03-3108344447bus:OrdinaryShareClass32024-03-3108344447bus:OrdinaryShareClass42025-03-3108344447bus:OrdinaryShareClass42024-03-3108344447bus:OrdinaryShareClass52025-03-3108344447bus:OrdinaryShareClass52024-03-3108344447bus:AllOrdinaryShares2025-03-3108344447bus:AllOrdinaryShares2024-03-3108344447core:WithinOneYear2025-03-3108344447core:WithinOneYear2024-03-3108344447core:OtherRelatedPartiescore:SaleOrPurchaseGoods2024-04-012025-03-3108344447core:OtherRelatedPartiescore:SaleOrPurchaseGoods2023-04-012024-03-3108344447bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108344447bus:FRS1022024-04-012025-03-3108344447bus:Audited2024-04-012025-03-3108344447bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP